Chi Wang
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Histone Deacetylase Inhibitors Research
- Cancer-related gene regulation
Papers in
-
- Ubiquitin and proteasome pathways 5
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 4
- Wnt/β-catenin signaling in development and cancer 3
- Oncology 14
- Cancer-related Molecular Pathways 4
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- Daheng He (10 shared papers)Tianyan Gao (7 shared papers)B. Mark Evers (11 shared papers)Zhichuan Li (1 shared paper)Moumita Banerjee (1 shared paper)Xiaoyu Cui (1 shared paper)Liquan Cai (1 shared paper)Hui Yu (1 shared paper)
- Journals
- Nature Communications (4 papers)Cancer Research (4 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)PLoS ONE (3 papers)Free Radical Biology and Medicine (2 papers)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Chi Wang
52 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 167
- Cancer Research 391
- Molecular Biology 1.2k
- Oncology 372
- Cell Biology 124
- Immunology 140
Countries citing papers authored by Chi Wang
This map shows the geographic impact of Chi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Wang more than expected).
Fields of papers citing papers by Chi Wang
This network shows the impact of papers produced by Chi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Wang. The network helps show where Chi Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Na/K-ATPase Y260 Phosphorylation–mediated Src Regulation in Control of Aerobic Glycolysis and Tumor Growth Hit paper breakdown → | 2018 | 468 |
| 2 | 2013 | 143 | |
| 3 | 2017 | 115 | |
| 4 | 2020 | 85 | |
| 5 | 1999 | 77 | |
| 6 | 2020 | 76 | |
| 7 | 2014 | 72 | |
| 8 | 2020 | 71 | |
| 9 | 2019 | 69 | |
| 10 | 2018 | 62 | |
| 11 | 2018 | 58 | |
| 12 | 2014 | 58 | |
| 13 | 2012 | 49 | |
| 14 | 2017 | 48 | |
| 15 | 2017 | 37 | |
| 16 | 2017 | 37 | |
| 17 | 2022 | 35 | |
| 18 | 2015 | 34 | |
| 19 | 2018 | 34 | |
| 20 | 2020 | 33 |
About Chi Wang
Chi Wang is a scholar working on Molecular Biology, Oncology, Cancer Research, Cell Biology and Physiology, having authored 52 papers that have together received 2.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Ubiquitin and proteasome pathways (5 papers), Cancer-related Molecular Pathways (4 papers), RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). The work is most often cited by research in Cancer Research (391 citations), Molecular Biology (1.2k citations), Oncology (372 citations), Cell Biology (124 citations) and Immunology (140 citations). Chi Wang has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Daheng He, Tianyan Gao, B. Mark Evers, Zhichuan Li, Moumita Banerjee, Xiaoyu Cui, Liquan Cai, Hui Yu, Zijian Xie and Yekaterina Y. Zaytseva. Their work appears in journals such as Nature Communications, Cancer Research, Journal of Pharmacology and Experimental Therapeutics, PLoS ONE and Free Radical Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.